Reps. Kuster, Miller-Meeks, Murphy, Barragan Introduce Bipartisan Bill to Lower Drug Prices, Expedite Substitution Process for Pharmaceuticals
September 21, 2022
September 21, 2022
WASHINGTON, Sept. 21 -- Rep. Ann Kuster, D-New Hampshire, issued the following news release:
Representatives Annie Kuster (D-NH-02), Mariannette Miller-Meeks (R-IA-02), Greg Murphy (R-NC-03), and Nanette Barragan (D-CA-44) introduced the Biologics Competition Act, legislation to direct the Secretary of Health and Human Services to evaluate the process by which interchangeable biological products are approved to be used in pharmaceuticals. In many cases, these products are more affor . . .
Representatives Annie Kuster (D-NH-02), Mariannette Miller-Meeks (R-IA-02), Greg Murphy (R-NC-03), and Nanette Barragan (D-CA-44) introduced the Biologics Competition Act, legislation to direct the Secretary of Health and Human Services to evaluate the process by which interchangeable biological products are approved to be used in pharmaceuticals. In many cases, these products are more affor . . .